Related Experiment Video
Updated: May 16, 2026
Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
[Lacrimal duct tumors: diagnostic and therapeutic dilemmas]
S Deneuve1, F Bidault, O Casiraghi
1Département de chirurgie cervicofaciale, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France. fdeneuve@club-internet.fr
Introduction:
Fewer than 250 primary tumors of the lacrimal duct have been reported in the international literature. Because their signs and symptoms are nonspecific and usually subclinical, delayed diagnosis is common. Treatment for malignant epithelial tumors is surgical, with or without radiation.
Patients And Methods:
The present study is a retrospective analysis of five patients with malignant lacrimal duct tumors.
Results:
Three patients were diagnosed with carcinoma requiring wide en bloc surgical resection with surgical reconstruction. One underwent adjuvant radiation therapy. Another experienced simultaneous local and lymph node recurrence after 3 years and underwent curative surgery. Two additional patients were diagnosed with diffuse malignant large B-cell non-Hodgkins lymphoma.
Discussion:
Early symptoms of lacrimal duct tumors are nonspecific and mimic acute dacryocystitis. Lacrimal system CT, MRI and rhinoscopy may allow for earlier diagnosis. Surgical treatment requires resection with wide margins and reconstruction of the medial canthal region.
Conclusion:
Only an early diagnosis can reduce the impairment related to surgery and the extent of the required reconstruction, as well as improve survival.
